DE SARRO, Angelina
 Distribuzione geografica
Continente #
NA - Nord America 4.391
EU - Europa 4.116
AS - Asia 2.321
SA - Sud America 760
Continente sconosciuto - Info sul continente non disponibili 84
AF - Africa 75
OC - Oceania 4
Totale 11.751
Nazione #
US - Stati Uniti d'America 4.310
RU - Federazione Russa 1.980
SG - Singapore 993
BR - Brasile 660
CN - Cina 660
SE - Svezia 524
IE - Irlanda 511
UA - Ucraina 344
HK - Hong Kong 240
DE - Germania 234
VN - Vietnam 187
GB - Regno Unito 149
FI - Finlandia 121
FR - Francia 105
IN - India 66
IT - Italia 42
CA - Canada 35
AR - Argentina 32
BD - Bangladesh 26
MX - Messico 25
ZA - Sudafrica 23
JP - Giappone 21
EC - Ecuador 20
TR - Turchia 20
AT - Austria 19
BE - Belgio 17
PK - Pakistan 16
MA - Marocco 15
PL - Polonia 14
JO - Giordania 12
NL - Olanda 12
UZ - Uzbekistan 12
CL - Cile 10
CO - Colombia 10
ES - Italia 10
IQ - Iraq 10
AE - Emirati Arabi Uniti 9
CZ - Repubblica Ceca 8
EG - Egitto 8
PE - Perù 8
VE - Venezuela 8
RS - Serbia 6
UY - Uruguay 6
ID - Indonesia 5
MN - Mongolia 5
PY - Paraguay 5
TN - Tunisia 5
AZ - Azerbaigian 4
CI - Costa d'Avorio 4
CR - Costa Rica 4
DZ - Algeria 4
IL - Israele 4
IR - Iran 4
KE - Kenya 4
PA - Panama 4
SA - Arabia Saudita 4
SN - Senegal 4
DO - Repubblica Dominicana 3
JM - Giamaica 3
KR - Corea 3
NG - Nigeria 3
NP - Nepal 3
OM - Oman 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AU - Australia 2
BG - Bulgaria 2
BW - Botswana 2
EE - Estonia 2
EU - Europa 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
HU - Ungheria 2
LB - Libano 2
MY - Malesia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PR - Porto Rico 2
PS - Palestinian Territory 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
DK - Danimarca 1
ET - Etiopia 1
HR - Croazia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LT - Lituania 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
Totale 11.671
Città #
Jacksonville 674
Moscow 651
Singapore 553
Dublin 511
Ashburn 502
Dallas 490
Chandler 425
Beijing 265
Nyköping 263
Hong Kong 238
San Jose 184
Council Bluffs 132
Dong Ket 125
Princeton 105
Cambridge 104
Lauterbourg 92
The Dalles 92
Los Angeles 85
Boardman 84
Des Moines 78
Medford 76
Ann Arbor 65
Dearborn 51
Buffalo 50
Columbus 47
São Paulo 40
Woodbridge 37
Pune 29
Tianjin 27
New York 26
Wilmington 25
Guangzhou 24
Belo Horizonte 22
Ho Chi Minh City 22
Jinan 21
Orem 20
Rio de Janeiro 20
Lancaster 19
Redondo Beach 19
Houston 18
Shenyang 18
Vienna 18
Brussels 17
Seattle 15
Brooklyn 14
Frankfurt am Main 14
Hyderabad 14
London 14
Santa Clara 14
Montreal 13
Auburn Hills 12
Shenzhen 12
Tokyo 12
Warsaw 12
Curitiba 11
Hangzhou 11
Hanoi 11
Hebei 11
Helsinki 11
Johannesburg 11
Munich 11
Phoenix 11
Washington 11
Amman 10
Amsterdam 10
Ningbo 10
Poplar 10
Porto Alegre 10
Saint Petersburg 10
San Mateo 10
Stockholm 10
Tashkent 10
Campinas 9
Chicago 9
Monmouth Junction 9
Taizhou 9
Zhengzhou 9
Denver 8
Milan 8
Morikitamachi 8
Norwalk 8
Quito 8
Salvador 8
San Francisco 8
Shanghai 8
Ankara 7
Brasília 7
Casablanca 7
Contagem 7
Lima 7
Manchester 7
Mexico City 7
Nuremberg 7
Toronto 7
Turku 7
Atlanta 6
Augusta 6
Belgrade 6
Cape Town 6
Changsha 6
Totale 6.908
Nome #
1-aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: Novel AMPA receptor antagonists 302
1,4-benzodiazepine derivatives as anticonvulsant agents in DBA/2 mice 261
5-lipoxygenase knockout mice exhibit a resistance to acute pancreatitis induced by cerulein 246
5-AMINOISOQUINOLINONE REDUCES COLON INJURY BY EXPERIMENTAL COLITIS 235
3,5-dihydro-4H-2,3-benzodiazepine-4-thiones: A new class of AMPA receptor antagonists 212
Absence of endogenous interleukin-6 enhances the inflammatory response during acute pancreatitis induced by cerulein in mice 210
7,8-methylenedioxy-4H-2,3-benzodiazepin-4-ones as novel AMPA receptor antagonists 201
5H-[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines as anticonvulsant agents in DBA/2 mice. 194
Anticonvulsant activity of azirino[1,2-d][1,4]benzodiazepines and related 1,4-benzodiazepines in mice 192
Amoxicillin and amoxicillin plus clavulanate: a safety review 192
Activity and postantibiotic effect of marbofloxacin, enrofloxacin, difloxacin and ciprofloxacin against feline Bordetella bronchiseptica isolates 178
Azirino[1,2-d][1,4]benzodiazepine derivatives and related 1,4- benzodiazepines as anticonvulsant agents in DBA/2 mice 173
Activity of nine fluoroquinolones against strains of Bordetella bronchiseptica 167
Focus: Linguistic, cognitive, and computational perspectives 164
7-nitroindazole potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice 161
Anticonvulsant activity and plasma level of 2,3-benzodiazepin- 4-ones (CFMs) in genetically epilepsy-prone rats 160
Bactericidal activity of lansoprazole and three macrolides against Helicobacter pylori strains tested by the time-kill kinetic method 158
Amoxicillin and amoxicillin plus clavulanate: a safety review. 156
Attenuation in the evolution of experimental spinal cord trauma by treatment with melatonin 153
New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance 150
Adverse reactions to fluoroquinolones. An overview on mechanistic aspects 146
ANTICONVULSANT ACTIVITY OF PYRROLO[1',2'-1,2]IMIDAZO[4,5- B]PYRIDINES, PYRROLO[2',1'-2,3]IMIDAZO[4,5-C] PYRIDINES AND PYRROLO[2,1-F]PURINES IN DBA/2 MICE 143
Beneficial effects of GPI 6150, an inhibitor of poly(ADP-ribose) polymerase in a rat model of splanchnic artery occlusion and reperfusion 142
Amelioration of joint disease in a rat model of collagen- induced arthritis by M40403, a superoxide dismutase mimetic 136
Effects of tempol, a membrane-permeable radical scavenger, in a gerbil model of brain injury 135
BENEFICIAL EFFECTS OF 5-AMINOISOQUINOLINONE, A NOVEL, POTENT, WATER-SOLUBLE, INHIBITOR OF POLY(ADP-RIBOSE)POLYMERASE, IN A RAT MODEL OF SPLANCHNIC ARTERY OCCLUSION AND REPERFUSION 132
Beneficial effects of n-acetylcysteine on ischaemic brain injury 131
Geometric models in classical thermomechanics of continua with applications to irreversible phenomena 129
Novel potent AMPA/kainate receptor antagonists: Synthesis and anticonvulsant activity of a series of 2-[(4- alkylsemicarbazono)-(4-aminophenyl)methyl]-4,5- methylenedioxyphenylacetic acid alkyl esters 125
Synthesis and pharmacological evaluation of 4-aryl-6,7- dimethoxyphthalazines as anticonvulsant agents 120
Effects of n-acetylcysteine in a rat model of ischemia and reperfusion injury 117
Protective effects of melatonin in ischemic brain injury 114
Role of induced nitric oxide in the initiation of the inflammatory response after postischemic injury 114
Synthesis and anticonvulsant activity of novel and potent 6,7- methylenedioxyphthalazin-1(2H)-ones 114
NOVEL ANNELATED 1,4-BENZODIAZEPINES AND 1,5-BENZODIAZEPINES 113
Synthesis and anticonvulsant activity of novel and potent 1- aryl-7,8-methylenedioxy-1,2,3,5-tetrahydro-4H-2,3- benzodiazepin-4-ones 111
Regulation of prostaglandin generation in carrageenan-induced pleurisy by inducible nitric oxide synthase in knockout mice 111
Susceptibility to audiogenic seizure and neurotransmitter amino acid levels in different brain areas of IL-6-deficient mice 109
Effects of melatonin on ischemic brain injury 109
Synthesis and anticonvulsant activity of triazolo[4,5-c][2,3]benzodiazepines 108
Synthesis and pharmacological properties of new 3- ethoxycarbonyl-11H-[1,2,4]triazolo[4,5-c][2,3]benzodiazepines 106
Synthesis and anticonvulsant activity of novel and potent 2,3- benzodiazepine AMPA/kainate receptor antagonists 102
Comparative anticonvulsant activity of some 2,3-benzodiazepine derivatives in rodents 102
Synthesis and anticonvulsant activity of new 11H-triazolo[4,5- c] [2,3]benzodiazepines 100
Role of tight junction derangement in the endothelial dysfunction elicited by exogenous and endogenous peroxynitrite and poly(ADP-ribose) synthetase 100
Influence of carbenoxolone on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice 100
The tyrosine kinase inhibitor tyrphostin AG126 reduces the development of acute and chronic inflammation 99
Influence of retigabine on the anticonvulsant activity of some antiepileptic drugs against audiogenic seizures in DBA/2 mice 99
New and investigational antimicrobials for the treatment of severe skin infections 99
Role of 5-lipoxygenase in the multiple organ failure induced by zymosan 98
Protective effects of n-acetylcysteine on lung injury and red blood cell modification induced by carrageenan in the rat 98
New and investigational triazole agents for the treatment of invasive fungal infections 97
GYKI 52466 and related 2,3-benzodiazepines as anticonvulsant agents in DBA/2 mice 97
Beneficial effects of GW274150 treatment on the development of experimental colitis induced by dinitrobenzene sulfonic acid. 96
Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion 95
Synthesis and evaluation of pharmacological properties of novel annelated 2,3-benzodiazepine derivatives 95
Effect of N-acetylcysteine on gentamicin-mediated nephropathy in rats 95
Influence of some beta-adrenoceptor antagonists on the anticonvulsant potency of antiepileptic drugs against audiogenic seizures in DBA/2 mice 95
Linear hyperbolic systems of order-k in bounded and unbounded sets. Stability of complete controllability 94
RELATIONSHIP BETWEEN STRUCTURE AND CONVULSANT PROPERTIES OF SOME BETA-LACTAM ANTIBIOTICS FOLLOWING INTRACEREBROVENTRICULAR MICROINJECTION IN RATS 94
Benzodiazepine receptor affinities, behavioral, and anticonvulsant activity of 2-aryl-2,5-dihydropyridazino[4,3- b]indol-3(3H)-ones in mice 93
Influence of D-cycloserine on the anticonvulsant activity of some antiepileptic drugs against audiogenic seizures in DBA/2 mice 93
Beneficial effects of melatonin in a rat model of splanchnic artery occlusion and reperfusion 91
Structure-activity relationships in thienodiazepine and benzodiazepine derivatives. 90
Convulsant effects of some xanthine: Derivatives in genetically epilepsy-prone rats 90
Green tea polyphenol extract attenuates colon injury induced by experimental colitis 89
Inducible nitric oxide synthase - Knockout mice exhibit resistance to pleurisy and lung injury caused by carrageenan 89
ERYTHROPOIETIN REDUCES THE DEVELOPMENT OF EXPERIMENTAL INFLAMMATORY BOWEL DISEASE 88
Quinolones potentiate cefazolin-induced seizures in DBA/2 mice. 88
Protective effects of Celecoxib on lung injury and red blood cells modification induced by carrageenan in the rat 88
NMDA and AMPA/kainate receptors are involved in the anticonvulsant activity of riluzole in DBA/2 mice 87
Synthesis and anticonvulsant properties of 2,3,3a,4-tetrahydro- 1H-pyrrolo[1,2-a]benzimidazol-1-one derivatives 87
Tolerance and pharmacokinetics of ciprofloxacin in the chick. Preliminary experience in subjects of pediatric age with urinary tract infections (UTI) 87
Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats 85
Topiramate potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice 85
Effects of compounds acting on GABA(B) receptors in the pentylenetetrazole kindling model of epilepsy in mice 84
Role of interleukin-6 in a non septic shock model induced by zymosan 84
SYNTHESIS AND ANTICONVULSANT PROPERTIES OF 3-(1,3,4-THIADIAZOL- 2-YL)THIAZOLIDIN-4-ONES 84
Comparative anticonvulsant activity of N-acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives in rodents 83
Effects of some AMPA receptor antagonists on the development of tolerance in epilepsy-prone rats and in pentylenetetrazole kindled rats 83
Role of interleukin-6 in a non-septic shock model induced by zymosan 83
Role of IL-6 in the pleurisy and lung injury caused by carrageenan 83
Inducibile nitric oxide synthase knock out mice exhibit resistance to pleurisy lung injury caused by carrageenan 82
Effects of some excitatory amino acid antagonists and drugs enhancing gamma-aminobutyric acid neurotransmission on pefloxacin-induced seizures in DBA/2 mice 82
Effect of melatonin on cellular energy depletion mediated by peroxynitrite and poly (ADP-ribose) synthetase activation in an acute model of inflammation 82
The charta of milan: basic criteria for the appropriate and accurate use of antibiotics: recommendations of the italian society of chemotherapy. 82
Enhanced susceptibility of pentylenetetrazole kindled mice to quinolone effects 80
WWW.ecm.farmacovigilanza.org: An Italian website for CME in pharmacovigilance 80
Role of interleukin-6 in splanchnic artery occlusion shock. 79
Synthesis and anticonvulsant activity of new 2,3- benzodiazepines as AMPA receptor antagonists 79
Molecular requirement for anticonvulsant activity in a series of thiazolo-1,4-benzodiazepine derivatives and comparison with classical benzodiazepines. 76
Seizure susceptibility to various convulsant stimuli of knockout interleukin-6 mice 74
Reversible orofacial dyskinesia after ofloxacin treatment 73
Relationship between anticonvulsant activity and plasma level of some 2,3-benzodiazepines in genetically epilepsy-prone rats 73
Synthesis and anticonvulsant activity of novel non competitive as AMPA receptor antagonists. 72
Role of free radicals and poly(ADP-ribose) synthetase in intestinal tight junction permeability 71
INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE MODULATE SIGNAL TRANSDUCTION PATHWAYS AND SECONDARY DAMAGE IN EXPERIMENTAL SPINAL CORD TRAUMA. 71
Interleukin-6 knock out mice exhibit a resistance to splanchnic artery occlusion shock 70
THALIDOMIDE TREATMENT REDUCES COLON INJURY INDUCED BY EXPERIMENTAL COLITIS 70
Synthesis and evaluation of pharmacological and pharmacokinetic properties of 11H-[1,2,4]triazolo[4,5-c][2,3]benzodiazepin- 3(2H)-ones 65
Totale 11.560
Categoria #
all - tutte 40.462
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.462


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022619 0 79 16 11 24 0 40 28 6 66 156 193
2022/20231.704 146 106 52 139 161 191 21 131 659 11 70 17
2023/2024466 52 70 27 108 25 84 12 47 1 16 4 20
2024/20251.750 20 18 58 113 101 35 9 477 449 59 111 300
2025/20264.639 161 303 455 310 423 1.189 532 504 485 157 69 51
2026/2027259 74 185 0 0 0 0 0 0 0 0 0 0
Totale 11.751